Goldman says S&P can surpass 3,600
The potential for an early vaccine and the outlook for U.S. growth mean there's room for stocks to go higher, analysts say
U.S. stocks likely have more upside as they factor in American growth prospects and the COVID-19 vaccine outlook, according to Goldman Sachs Group Inc.
The implied level of the S&P 500 could be above 3,600, strategists Dominic Wilson and Vickie Chang wrote in a note Thursday. That’s if mark
Learn more about reprints and licensing for this article.